Musashi-2 Antibody (960121) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3255I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunocytochemistry
Label
Janelia Fluor 549
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 960121
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human Musashi-2
Met1-His328
Accession # Q96DH6
Met1-His328
Accession # Q96DH6
Specificity
Detects human Musashi-2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Musashi-2 Antibody (960121) [Janelia Fluor® 549]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Musashi-2
Alternate Names
MSI2, Musashi2
Additional Musashi-2 Products
Product Documents for Musashi-2 Antibody (960121) [Janelia Fluor® 549]
Product Specific Notices for Musashi-2 Antibody (960121) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...